Biotech 15 Year Financial Model Template

Clinics, Financial Model, Health Care, Hospitals, Laboratories, Life Science, Pharmacies & Drugstores

10-year Financial Projections, 5-year Financial Projections, Business Valuation, Cash Flow Analysis, DCF Model, Excel, Financial Analysis, Financial Model, Financial Modeling, Financial modelling, Financial Planning, Financial Projections, Financial Ratios, Financial Reporting, Financial Statements, Financing, Forecast, Forecasting, Income Statement, Revenue Projections, Valuation Services

Biotech Financial Model — Full 21-Tab Excel Template

Build investor-ready biotech financial projections in hours, not weeks. This fully integrated Excel model covers the entire pharmaceutical value chain — pipeline, clinical trials, probability of success, launch, revenue, and cash flow — with a genuine three-statement model (P&L, cash flow, balance sheet), rNPV and DCF valuation, bull/base/bear scenario analysis, and a full investor cap table with dilution and IRR/MOIC.

Every date, formula, and assumption is dynamically linked: change one input — like the model start date or active scenario — and all 21 tabs, 15 years of forecasts, and every downstream calculation update automatically. No broken links, no manual re-work, no circular reference errors.

Built for biotech founders, CFOs, VCs, equity research analysts, and consultants who need a model that reflects how pharma companies actually create value: pipeline → milestones → probability of success → launch → patients → price → revenue → cash.

Why buy this model: Most templates bolt biotech labels onto a generic SaaS model. This one is built from the real mechanics of drug development from the ground up — so every number, from R&D burn to valuation to your cap table, is driven by actual pipeline logic, not guesswork.

What’s Inside (21 Tabs)

Pipeline & Development — Programs, phases, probability of success, trial timelines, patient enrollment, and R&D cost build, all auto-phased by month
Commercial & Revenue — Launch curves, pricing, market share, and 20+ revenue lines (drug sales, diagnostics, manufacturing, royalties, recurring contracts)
Core Financials — COGS, opex, headcount, capex/D&A, and a full three-statement model that balances perfectly in every period
Financing & Valuation — Debt/equity schedule, rNPV and DCF valuation, bull/base/bear scenarios, and a complete cap table with exit returns
Governance — Built-in error-checking tab (PASS/REVIEW flags) and a one-page KPI dashboard

FAQ

Is this generic or biotech-specific? Purpose-built for biotech — driven by pipeline, trial phases, and probability of success, not renamed SaaS metrics.
Do I need Excel expertise? No — inputs are color-coded and every tab is documented.
Can I change the start date? Yes, one cell re-dates the entire 15-year model instantly.
Does it calculate valuation? Yes — per-program rNPV plus a full company DCF with terminal value.
Will the balance sheet actually balance? Yes, by construction, in every period — no manual plugs.
Does it work in Google Sheets? Yes — built with standard formulas that import cleanly.

You must log in to submit a review.